FI98196B - Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsion - Google Patents
Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsionInfo
- Publication number
- FI98196B FI98196B FI894637A FI894637A FI98196B FI 98196 B FI98196 B FI 98196B FI 894637 A FI894637 A FI 894637A FI 894637 A FI894637 A FI 894637A FI 98196 B FI98196 B FI 98196B
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- microemulsion
- pharmaceutical
- pharmaceutical preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000004530 micro-emulsion Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8822857 | 1988-09-29 | ||
GB888822857A GB8822857D0 (en) | 1988-09-29 | 1988-09-29 | Pharmaceutical formulations |
Publications (4)
Publication Number | Publication Date |
---|---|
FI894637A0 FI894637A0 (sv) | 1989-09-29 |
FI894637A FI894637A (sv) | 1990-03-30 |
FI98196B true FI98196B (sv) | 1997-01-31 |
FI98196C FI98196C (sv) | 1997-05-12 |
Family
ID=10644447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI894637A FI98196C (sv) | 1988-09-29 | 1989-09-29 | Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsion |
Country Status (28)
Country | Link |
---|---|
US (1) | US5656289A (sv) |
EP (1) | EP0366277B1 (sv) |
JP (1) | JP2927835B2 (sv) |
KR (1) | KR0139641B1 (sv) |
AR (1) | AR243375A1 (sv) |
AT (1) | ATE98480T1 (sv) |
AU (2) | AU4341789A (sv) |
BG (1) | BG60849B1 (sv) |
CA (1) | CA1339814C (sv) |
CZ (1) | CZ285237B6 (sv) |
DD (1) | DD300405A5 (sv) |
DE (1) | DE68911473T2 (sv) |
DK (1) | DK481989A (sv) |
ES (1) | ES2060785T3 (sv) |
FI (1) | FI98196C (sv) |
GB (1) | GB8822857D0 (sv) |
HK (1) | HK85596A (sv) |
HU (2) | HUT54033A (sv) |
IE (1) | IE63543B1 (sv) |
MX (1) | MX17752A (sv) |
NO (1) | NO300199B1 (sv) |
NZ (1) | NZ230838A (sv) |
PL (1) | PL163635B1 (sv) |
PT (1) | PT91850B (sv) |
RO (1) | RO108219B1 (sv) |
RU (1) | RU2122403C1 (sv) |
WO (1) | WO1990003164A2 (sv) |
ZA (1) | ZA897437B (sv) |
Families Citing this family (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443841A (en) | 1992-06-15 | 1995-08-22 | Emisphere Technologies, Inc. | Proteinoid microspheres and methods for preparation and use thereof |
US5693338A (en) | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US5541155A (en) | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
US6099856A (en) | 1992-06-15 | 2000-08-08 | Emisphere Technologies, Inc. | Active agent transport systems |
US5578323A (en) | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
US5451410A (en) * | 1993-04-22 | 1995-09-19 | Emisphere Technologies, Inc. | Modified amino acids for encapsulating active agents |
US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
US5447728A (en) * | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
GB9022788D0 (en) * | 1990-10-19 | 1990-12-05 | Cortecs Ltd | Pharmaceutical formulations |
US5206219A (en) * | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
US5614219A (en) * | 1991-12-05 | 1997-03-25 | Alfatec-Pharma Gmbh | Oral administration form for peptide pharmaceutical substances, in particular insulin |
DE4140179C2 (de) * | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Ibuprofen enthaltendes Arzneimittel |
DE4140185C2 (de) * | 1991-12-05 | 1996-02-01 | Alfatec Pharma Gmbh | Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung |
EP0617626A1 (en) * | 1991-12-18 | 1994-10-05 | Pfizer Inc. | Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
US5525519A (en) * | 1992-01-07 | 1996-06-11 | Middlesex Sciences, Inc. | Method for isolating biomolecules from a biological sample with linear polymers |
BR9201168A (pt) * | 1992-04-02 | 1994-04-12 | Zerbini E J Fundacao | Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas |
US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
US5811127A (en) | 1992-06-15 | 1998-09-22 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US6153592A (en) * | 1992-11-09 | 2000-11-28 | Port Systems, Llc | Enhancing the bioavailability of proteolytically labile therapeutic agents |
US5401516A (en) | 1992-12-21 | 1995-03-28 | Emisphere Technologies, Inc. | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
TW438603B (en) * | 1993-04-19 | 2001-06-07 | Advanced Skin Res Kenkyusho Kk | Microemulsion preparation containing peptide pharmaceuticals |
US5766633A (en) | 1993-04-22 | 1998-06-16 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5958457A (en) | 1993-04-22 | 1999-09-28 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
US5709861A (en) | 1993-04-22 | 1998-01-20 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
US5514670A (en) * | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
AU7706494A (en) * | 1993-09-29 | 1995-04-18 | Technobiochip | Protein thin films and compositions for use in their preparation |
PT726761E (pt) * | 1993-11-03 | 2001-07-31 | Isomed Inc | Composicoes farmaceuticas que microparticulas na forma de micelios |
GB9325445D0 (en) * | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
US5858398A (en) * | 1994-11-03 | 1999-01-12 | Isomed Inc. | Microparticular pharmaceutical compositions |
GB9424902D0 (en) * | 1994-12-09 | 1995-02-08 | Cortecs Ltd | Solubilisation Aids |
WO1996024332A1 (en) * | 1995-02-06 | 1996-08-15 | Nanosystems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US5650386A (en) | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
US6001347A (en) | 1995-03-31 | 1999-12-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5989539A (en) | 1995-03-31 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5866536A (en) | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6090958A (en) | 1995-03-31 | 2000-07-18 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5965121A (en) | 1995-03-31 | 1999-10-12 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
BR9604880A (pt) | 1995-03-31 | 1998-05-19 | Emisphere Tech Inc | Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica |
US5820881A (en) | 1995-04-28 | 1998-10-13 | Emisphere Technologies, Inc. | Microspheres of diamide-dicarboxylic acids |
US5750147A (en) | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
US6051258A (en) | 1995-06-07 | 2000-04-18 | Emisphere Technologies, Inc. | Proteinoid emulsions and methods for preparation and use thereof |
US5667806A (en) | 1995-06-07 | 1997-09-16 | Emisphere Technologies, Inc. | Spray drying method and apparatus |
US5824345A (en) | 1995-06-07 | 1998-10-20 | Emisphere Technologies, Inc. | Fragrances and flavorants |
WO1997010197A1 (en) | 1995-09-11 | 1997-03-20 | Emisphere Technologies, Inc. | METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES |
AU716747B2 (en) * | 1996-02-12 | 2000-03-02 | Csl Limited | Stabilised growth hormone formulation and method of preparation thereof |
AUPN801296A0 (en) * | 1996-02-12 | 1996-03-07 | Csl Limited | Stabilised growth hormone formulation and method of preparation thereof |
WO1997047288A1 (en) | 1996-06-14 | 1997-12-18 | Emisphere Technologies, Inc. | Microencapsulated fragrances and method for preparation |
EP0910343A1 (en) * | 1996-07-03 | 1999-04-28 | University Of Pittsburgh | Emulsion formulations for hydrophilic active agents |
US7255877B2 (en) * | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles |
US6465016B2 (en) * | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
US6150164A (en) * | 1996-09-30 | 2000-11-21 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
ES2130056B1 (es) * | 1997-01-16 | 2000-02-01 | Lipotec Sa | Un nuevo preparado farmaceutico para mejorar la biodisponibilidad oral de drogas de dificil absorcion. |
US5804688A (en) | 1997-02-07 | 1998-09-08 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5879681A (en) | 1997-02-07 | 1999-03-09 | Emisphere Technolgies Inc. | Compounds and compositions for delivering active agents |
US5990166A (en) | 1997-02-07 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6313088B1 (en) | 1997-02-07 | 2001-11-06 | Emisphere Technologies, Inc. | 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents |
US6060513A (en) | 1997-02-07 | 2000-05-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5876710A (en) | 1997-02-07 | 1999-03-02 | Emisphere Technologies Inc. | Compounds and compositions for delivering active agents |
US5939381A (en) | 1997-02-07 | 1999-08-17 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5863944A (en) | 1997-04-30 | 1999-01-26 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5962710A (en) | 1997-05-09 | 1999-10-05 | Emisphere Technologies, Inc. | Method of preparing salicyloylamino acids |
US6054421A (en) * | 1997-09-23 | 2000-04-25 | Scimed Life Systems, Inc. | Medical emulsion lubricant |
US6281175B1 (en) | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
US6221378B1 (en) | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
US7070799B1 (en) * | 1998-02-10 | 2006-07-04 | Generex Pharmaceuticals, Inc. | Method for administering insulin to the buccal region |
US6017545A (en) * | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
AU764001B2 (en) | 1998-05-29 | 2003-08-07 | Skyepharma Canada Inc. | Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
US6660277B1 (en) | 1998-06-19 | 2003-12-09 | Avon Products, Inc. | Gel matrix non-emulsion composition containing two clay gels |
ATE462417T1 (de) * | 1998-08-13 | 2010-04-15 | Cima Labs Inc | Microemulsionen als feste dosisformen zur oralen verabreichung |
AU767154B2 (en) | 1998-11-20 | 2003-10-30 | Skyepharma Canada Inc. | Dispersible phospholipid stabilized microparticles |
DE19855819C2 (de) * | 1998-12-03 | 2001-02-15 | Roche Diagnostics Gmbh | Stabilisierung von Cytokeratin enthaltenden Kalibratoren |
AU769539B2 (en) | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6267985B1 (en) | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
US6248354B1 (en) * | 1999-03-04 | 2001-06-19 | Allergan Sales, Inc. | Capsule system |
EP1181036B1 (en) | 1999-04-09 | 2008-07-23 | Ortho-Mcneil Pharmaceutical, Inc. | Pharmaceutical compositions of erythropoietin |
US6176849B1 (en) * | 1999-05-21 | 2001-01-23 | Scimed Life Systems, Inc. | Hydrophilic lubricity coating for medical devices comprising a hydrophobic top coat |
US6610035B2 (en) | 1999-05-21 | 2003-08-26 | Scimed Life Systems, Inc. | Hydrophilic lubricity coating for medical devices comprising a hybrid top coat |
US6458383B2 (en) | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
US6982281B1 (en) * | 2000-11-17 | 2006-01-03 | Lipocine Inc | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
US6309663B1 (en) | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
AU730929B2 (en) * | 1999-07-06 | 2001-03-22 | Nestec S.A. | Composition and method for prolonging the useful life of enteral feeding tubes |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
US6417237B1 (en) * | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
US6692771B2 (en) * | 2001-02-23 | 2004-02-17 | Cima Labs Inc. | Emulsions as solid dosage forms for oral administration |
US6951655B2 (en) * | 2001-10-11 | 2005-10-04 | Imi Biomed, Inc. | Pro-micelle pharmaceutical compositions |
DE10158447B4 (de) * | 2001-11-30 | 2005-02-10 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Ascorbinsäure-Solubilisat |
ITMI20012694A1 (it) * | 2001-12-19 | 2003-06-19 | Remedia S R L | Composizione farmaceutica comprendente una microemulsione doppia olio/acqua/olio incorporata in un supporto solido |
SI21258A (sl) * | 2002-07-17 | 2004-02-29 | LEK farmacevtska dru�ba d.d. | Stabilni farmacevtski pripravek, ki vsebuje eritropoietin in poloksamerni poliol |
KR100533460B1 (ko) * | 2002-07-20 | 2005-12-08 | 대화제약 주식회사 | 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법 |
AU2003262059A1 (en) * | 2002-09-11 | 2004-04-30 | Takeda Pharmaceutical Company Limited | Sustained release preparation |
FR2851918B1 (fr) * | 2003-03-06 | 2006-06-16 | Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication | |
EP1537876A1 (en) * | 2003-12-01 | 2005-06-08 | BioGeneriX AG | Erythropoietin solution formulation |
MXPA06011871A (es) * | 2004-04-15 | 2007-10-08 | Chiasma Inc | Composiciones capaces de facilitar la penetracion a traves de una barrera biologica. |
WO2005115340A1 (en) * | 2004-05-19 | 2005-12-08 | Glatt Air Techniques, Inc. | Micropellet containing pellets and method of preparing such pellets |
EP1652513A1 (en) * | 2004-11-02 | 2006-05-03 | Denderah Pharm Sa | Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof |
US20070071779A1 (en) * | 2005-09-26 | 2007-03-29 | Leggit Ingenuity, Llc | Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof |
WO2007127787A2 (en) * | 2006-04-25 | 2007-11-08 | Joslin Diabetes Center, Inc. | Insulin autoantigen-specific regulatory cd4+ t cells |
US9918934B2 (en) * | 2006-12-12 | 2018-03-20 | Edgar Joel Acosta-Zara | Linker-based lecithin microemulsion delivery vehicles |
DK1985188T3 (da) * | 2007-04-24 | 2013-04-02 | Gen Biscuit | Fremgangsmåde til at sprøjte et lag indeholdende fedt og sukker på en overflade af et spiseligt produkt |
WO2009042114A2 (en) | 2007-09-21 | 2009-04-02 | The Johns Hopkins University | Phenazine derivatives and uses thereof |
CN101772352B (zh) * | 2007-09-27 | 2012-05-23 | 理研维他命株式会社 | 软胶囊填充用液态组合物 |
JP5156458B2 (ja) * | 2008-03-31 | 2013-03-06 | 理研ビタミン株式会社 | ソフトカプセル充填用液状組成物 |
WO2010032140A2 (en) | 2008-09-17 | 2010-03-25 | Chiasma Inc. | Pharmaceutical compositions and related methods of delivery |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US9307758B2 (en) | 2009-06-19 | 2016-04-12 | Exacto, Inc. | Polyacrylamide based agricultural compositions |
US9309378B2 (en) | 2009-06-19 | 2016-04-12 | Exacto, Inc. | Emulsion compositions comprising polyacrylamide copolymer and ethylene oxide—propylene oxide copolymer |
US9428630B2 (en) | 2009-06-19 | 2016-08-30 | Exacto, Inc. | Water-in-oil polyacrylamide-based microemulsions and related methods |
CN101756900B (zh) * | 2010-02-25 | 2012-05-30 | 谢恬 | 一种榄香烯微乳 |
JP5406110B2 (ja) * | 2010-04-20 | 2014-02-05 | 日東電工株式会社 | 半導体ウエハ加工用粘着シート |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
KR101786532B1 (ko) * | 2013-12-11 | 2017-10-18 | 헬스-에버 바이오테크 컴퍼니 리미티드 | 카로테노이드의 약제 조성물 |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
MA41462A (fr) | 2015-02-03 | 2021-05-12 | Chiasma Inc | Méthode de traitement de maladies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
GB201808564D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Treatments |
EP3820455B1 (en) * | 2018-07-10 | 2024-06-19 | Universidade de Santiago de Compostela | Nanostructure lipid system |
DE102019211195A1 (de) * | 2019-07-26 | 2021-01-28 | Add Advanced Drug Delivery Technologies Ltd. | Verfahren und Vorrichtung zur Herstellung eines im Wesentlichen im wässrigen Milieu lösbaren Cannabinoid-Granulats |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
CN116828998A (zh) * | 2021-02-08 | 2023-09-29 | 比利时胶囊公司 | 缓释维生素c及其制造 |
WO2023017537A1 (en) | 2021-08-12 | 2023-02-16 | Celagenex Research (India) Pvt. Ltd. | Oral algal oil based gastro-intestinal tract permeable peptide composition |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4165385A (en) * | 1973-05-29 | 1979-08-21 | Dianis Creations, Inc. | Water-in-oil emulsion for skin moisturizing |
US4146499A (en) * | 1976-09-18 | 1979-03-27 | Rosano Henri L | Method for preparing microemulsions |
JPS5517328A (en) * | 1978-07-21 | 1980-02-06 | Tanabe Seiyaku Co Ltd | Insulin-containing emulsion and its preparation |
JPS55153713A (en) * | 1979-05-02 | 1980-11-29 | Kureha Chem Ind Co Ltd | Pharmaceutical preparation of ribosome containing active substance |
JPS5770814A (en) * | 1980-10-17 | 1982-05-01 | Isamu Horikoshi | Oral preparation of blood clotting eighth factor |
JPS5772920A (en) * | 1980-10-27 | 1982-05-07 | Toyama Chem Co Ltd | Carcinostatic agent containing blood plasma or blood serumal lipoprotein |
JPS5821622A (ja) * | 1981-07-28 | 1983-02-08 | Kowa Co | 糖尿病治療用薬剤 |
JPS5916534A (ja) * | 1982-07-19 | 1984-01-27 | Lion Corp | 非イオン性界面活性剤系ベシクル分散液 |
JPS6058915A (ja) * | 1983-09-12 | 1985-04-05 | Fujisawa Pharmaceut Co Ltd | 薬物含有脂質小胞体製剤 |
JPS60155109A (ja) * | 1984-01-23 | 1985-08-15 | Terumo Corp | リポソ−ム製剤 |
JPS6172721A (ja) * | 1984-09-19 | 1986-04-14 | Daigo Eiyou Kagaku Kk | インシユリン含有リポゾ−ム |
FR2581543B1 (fr) * | 1985-05-09 | 1989-07-07 | Tressens Dominique | Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale |
US4849227A (en) * | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
US4851220A (en) * | 1986-11-26 | 1989-07-25 | Schering Corporation | Stable oleaginous gel |
NZ222907A (en) * | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
US4839111A (en) * | 1987-02-02 | 1989-06-13 | The University Of Tennessee Research Corporation | Preparation of solid core liposomes |
US4855090A (en) * | 1987-03-13 | 1989-08-08 | Micro-Pak, Inc. | Method of producing high aqueous volume multilamellar vesicles |
US4853228A (en) * | 1987-07-28 | 1989-08-01 | Micro-Pak, Inc. | Method of manufacturing unilamellar lipid vesicles |
JPH06172721A (ja) * | 1992-09-03 | 1994-06-21 | Hitachi Kasei Polymer Kk | 研磨材固定用テープ |
-
1988
- 1988-09-29 GB GB888822857A patent/GB8822857D0/en active Pending
-
1989
- 1989-09-28 HU HU895107A patent/HUT54033A/hu unknown
- 1989-09-29 PT PT91850A patent/PT91850B/pt not_active IP Right Cessation
- 1989-09-29 DD DD333127A patent/DD300405A5/de unknown
- 1989-09-29 NZ NZ230838A patent/NZ230838A/en unknown
- 1989-09-29 CZ CS895548A patent/CZ285237B6/cs not_active IP Right Cessation
- 1989-09-29 PL PL89281635A patent/PL163635B1/pl unknown
- 1989-09-29 FI FI894637A patent/FI98196C/sv not_active IP Right Cessation
- 1989-09-29 ZA ZA897437A patent/ZA897437B/xx unknown
- 1989-09-29 EP EP89309989A patent/EP0366277B1/en not_active Expired - Lifetime
- 1989-09-29 CA CA000614764A patent/CA1339814C/en not_active Expired - Fee Related
- 1989-09-29 WO PCT/GB1989/001161 patent/WO1990003164A2/en unknown
- 1989-09-29 RO RO141815A patent/RO108219B1/ro unknown
- 1989-09-29 DK DK481989A patent/DK481989A/da not_active Application Discontinuation
- 1989-09-29 BG BG89877A patent/BG60849B1/bg unknown
- 1989-09-29 NO NO893896A patent/NO300199B1/no not_active IP Right Cessation
- 1989-09-29 KR KR1019890014062A patent/KR0139641B1/ko not_active IP Right Cessation
- 1989-09-29 AU AU43417/89A patent/AU4341789A/en not_active Abandoned
- 1989-09-29 RU SU4742283A patent/RU2122403C1/ru active
- 1989-09-29 DE DE89309989T patent/DE68911473T2/de not_active Expired - Fee Related
- 1989-09-29 AR AR89315058A patent/AR243375A1/es active
- 1989-09-29 JP JP1255067A patent/JP2927835B2/ja not_active Expired - Lifetime
- 1989-09-29 IE IE311889A patent/IE63543B1/en not_active IP Right Cessation
- 1989-09-29 AT AT89309989T patent/ATE98480T1/de active
- 1989-09-29 ES ES89309989T patent/ES2060785T3/es not_active Expired - Lifetime
- 1989-09-29 AU AU42432/89A patent/AU625498B2/en not_active Ceased
- 1989-10-29 MX MX1775289A patent/MX17752A/es unknown
-
1994
- 1994-02-16 US US08/207,236 patent/US5656289A/en not_active Expired - Fee Related
-
1995
- 1995-06-29 HU HU95P/P00585P patent/HU211633A9/hu unknown
-
1996
- 1996-05-16 HK HK85596A patent/HK85596A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI98196B (sv) | Förfarande för framställning av en farmaceutisk beredning omfattande en mikroemulsion | |
FI892640A0 (sv) | Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition | |
FI98046B (sv) | Förfarande för framställning av en cyklosporin innehållande farmaceutisk sammansättning | |
NO177038C (no) | Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem | |
FI885884A0 (sv) | Förfarande för framställning av en långsamt frigörande farmaceutisk komposition | |
FI901787A0 (sv) | Förfarande för framställning av en läkemedel avgivande komposition | |
FI891021A0 (sv) | Förfarande för framställning av som läkemedel användbara 1,2,4-triazolderivat | |
FI890282A (sv) | Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat | |
FI900604A0 (sv) | Förfarande för framställning av en farmaceutisk sammansättning innehållande cyklosporin | |
FI92934B (sv) | Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat | |
FI893520A0 (sv) | Förfarande för framställning av en intravenös farmaceutisk sammansättning | |
FI891538A (sv) | Förfarande för framställning av farmaceutiskt användbara fenolsubstituerade gem-difosfonatderivat | |
FI871492A (sv) | Förfarande för framställning av som läkemedel användningsbara 2-tiometylsubstituerade 1,4-dihydropyridiner | |
PT86986A (pt) | Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments | |
PT91631A (pt) | A process for the preparation of cyclic graf-analogs ii | |
FI885039A0 (sv) | Förfarande för framställning av benanomicin A och B samt dexylosylbenanomicin B | |
FI881303A0 (sv) | Förfarande för framställning av ibuprofen | |
NO174766C (no) | Fremgangsmåte til fremstilling av en doseringsenhet for kontrollert administrering av diltiazem | |
NO177485C (no) | Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat | |
FI92065C (sv) | Förfarande för framställning av farmaceutiska piperidinderivat | |
NO179396C (no) | Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere | |
FI93107B (sv) | Förfarande för framställning av som läkemedel användbara 2-imino-6-polyfluoralkoxibenzotiazolderivat | |
FI94351B (sv) | Förfarande för framställning av terapeutiskt användbara peptidderivater | |
FI900145A (sv) | Förfarande för framställning av farmaceutiskt användbara 1,1-dioxo-cefem-4-karbotiolsyraderivat | |
PT87186A (pt) | Imidazothiadiazine derivatives a process for preparing the same and their use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed |
Owner name: PATRALAN LIMITED |